Center-Authored Papers

Filters: Author is Gyurkocza, Boglarka  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
No Keywords
Fang M, Storer BE, Wood B, Gyurkocza B, Sandmaier BM, Appelbaum FR.  2012.  Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.. Cancer. 118(9):2411-2419. Abstract
2009
Gyurkocza B, Cao TM, Storb R, Lange T, Leisenring WM, Franke GN, Sorror ML, Hoppe R, Maloney DG, Negrin RS et al..  2009.  Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(10):1314-22. Abstract
2010
Gyurkocza B, Rezvani A, Storb R.  2010.  Allogeneic hematopoietic cell transplantation: the state of the art.. Expert review of hematology. 3(3):285-99. Abstract
Gyurkocza B, Storb R, Storer BE, Chauncey TR, Lange T, Shizuru JA, Langston AA, Pulsipher MA, Bredeson CN, Maziarz RT et al..  2010.  Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2859-67. Abstract
2011
Gyurkocza B, Appelbaum FR.  2011.  Identifying older patients with acute myeloid leukemia who may be candidates for reduced-intensity hematopoietic cell transplantation.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(3):319-29;quiz330. Abstract
2012
Fang M, Storer BE, Wood B, Gyurkocza B, Sandmaier BM, Appelbaum FR.  2012.  Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.. Cancer. 118(9):2411-2419. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
2013
Storb R, Gyurkocza B, Storer BE, Sorror ML, Blume K, Niederwieser D, Chauncey TR, Pulsipher MA, Petersen FB, Sahebi F et al..  2013.  Graft-versus-host disease and graft-versus-tumor effects after allogeneic hematopoietic cell transplantation.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(12):1530-8. Abstract
Storb R, Gyurkocza B, Storer BE, Maloney DG, Sorror ML, Mielcarek M, Martin PJ, Sandmaier BM.  2013.  Allogeneic Hematopoietic Cell Transplantation Following Minimal Intensity Conditioning: Predicting Acute Graft-versus-Host Disease and Graft-versus-Tumor Effects.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 19(5):792-8. Abstract
Walter RB, Buckley SA, Pagel JM, Wood BL, Storer BE, Sandmaier BM, Fang M, Gyurkocza B, Delaney C, Radich JP et al..  2013.  Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.. Blood. 122(10):1813-21. Abstract
2014
Gyurkocza B, Gutman J, Nemecek ER, Bar M, Milano F, Ramakrishnan A, Scott B, Fang M, Wood B, Pagel JM et al..  2014.  Treosulfan, Fludarabine, and 2-Gy Total Body Irradiation Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 20(4):549-55. Abstract
Acute Disease
Gyurkocza B, Cao TM, Storb R, Lange T, Leisenring WM, Franke GN, Sorror ML, Hoppe R, Maloney DG, Negrin RS et al..  2009.  Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(10):1314-22. Abstract
Adolescent
Fang M, Storer BE, Wood B, Gyurkocza B, Sandmaier BM, Appelbaum FR.  2012.  Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.. Cancer. 118(9):2411-2419. Abstract
Gyurkocza B, Storb R, Storer BE, Chauncey TR, Lange T, Shizuru JA, Langston AA, Pulsipher MA, Bredeson CN, Maziarz RT et al..  2010.  Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2859-67. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Gyurkocza B, Cao TM, Storb R, Lange T, Leisenring WM, Franke GN, Sorror ML, Hoppe R, Maloney DG, Negrin RS et al..  2009.  Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(10):1314-22. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Adult
Gyurkocza B, Cao TM, Storb R, Lange T, Leisenring WM, Franke GN, Sorror ML, Hoppe R, Maloney DG, Negrin RS et al..  2009.  Salvage allogeneic hematopoietic cell transplantation with fludarabine and low-dose total body irradiation after rejection of first allografts.. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 15(10):1314-22. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Fang M, Storer BE, Wood B, Gyurkocza B, Sandmaier BM, Appelbaum FR.  2012.  Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.. Cancer. 118(9):2411-2419. Abstract
Gyurkocza B, Storb R, Storer BE, Chauncey TR, Lange T, Shizuru JA, Langston AA, Pulsipher MA, Bredeson CN, Maziarz RT et al..  2010.  Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(17):2859-67. Abstract
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Aged
Deeg HJ, Scott BL, Fang M, Shulman HM, Gyurkocza B, Myerson D, Pagel JM, Platzbecker U, Ramakrishnan A, Radich JP et al..  2012.  Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.. Blood. 120(7):1398-408. Abstract
Fang M, Storer BE, Wood B, Gyurkocza B, Sandmaier BM, Appelbaum FR.  2012.  Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.. Cancer. 118(9):2411-2419. Abstract